Anne H. Rowley

Northwestern University — United States

Medicine · Health Sciences

54h-index17.1kcitations189works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Kawasaki Disease and Coronary Complications(137), Coronary Artery Anomalies(67), Cardiovascular Issues in Pregnancy(28), Cardiac Structural Anomalies and Repair(27), Mechanical Circulatory Support Devices(22)

Publications183 total

Lack of Discernible Benefit of High-Dose Aspirin in the Treatment of Kawasaki Disease
2025Open Access
Monoclonal Antibodies From Children With Acute Kawasaki Disease Identify a Common Antigenic Target in Fatal Cases Over 5 Decades
Laboratory Investigation·2025· 4 citedOpen Access
519. Antibodies Produced by Children with Kawasaki Disease (KD) Consistently Recognize Antigen in KD Tissues from the US and Japan
Open Forum Infectious Diseases·2025Open Access
Kawasaki Disease
Elsevier eBooks·2025
Primary Adjunctive Corticosteroids in the Acute Management of High-Risk Kawasaki Disease in a North American Cohort
Journal of the Pediatric Infectious Diseases Society·2024· 2 cited
Coronary Artery Outcomes in Kawasaki Disease by Treatment Day Within 10 Days of Fever Onset
Open Forum Infectious Diseases·2024· 3 citedOpen Access
523 Phase 1 study of SNSP-003—a non-porcine pancreatic enzyme replacement therapy—using a novel endpoint
Journal of Cystic Fibrosis·2023Open Access
Analysis of Plasmablasts From Children With Kawasaki Disease Reveals Evidence of a Convergent Antibody Response to a Specific Protein Epitope
The Journal of Infectious Diseases·2023· 9 citedOpen Access
Pediatric Vasculitis
2023
Kawasaki Disease
Elsevier eBooks·2022
Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States
JAMA Network Open·2022· 44 citedOpen Access
1177. Vaccinate Lurie (VaLu) a QI Project to Improve Pediatric Pre-Transplant Immunization Rates
Open Forum Infectious Diseases·2021Open Access
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
The Lancet Child & Adolescent Health·2021· 93 citedOpen Access
Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children
Current Pediatrics Reports·2021· 69 citedOpen Access
An Unintended Consequence of Pandemic Control Measures: Fewer Cases of Kawasaki Disease
The Journal of Pediatrics·2021· 11 citedOpen Access
Human airway epithelial cell culture to identify new respiratory viruses: Coronavirus NL63 as a model
UNC Libraries·2021Open Access
Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study
Journal of Cardiovascular Magnetic Resonance·2021· 58 citedOpen Access
The Impact of Social Distancing for COVID-19 Upon Diagnosis of Kawasaki Disease
Journal of the Pediatric Infectious Diseases Society·2021· 32 citedOpen Access
1146. Thrombocytosis in Infants with Congenital Cytomegalovirus Infection Being Treated with Valganciclovir
Open Forum Infectious Diseases·2020Open Access
Immune pathogenesis of COVID-19–related multisystem inflammatory syndrome in children
Journal of Clinical Investigation·2020· 87 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Stanford T. Shulman(33), Susan C. Baker(11), Jane W. Newburger(10), Jane C. Burns(9), Masato Takahashi(8), Michael H. Gewitz(7), Kathryn A. Taubert(7), Susan E. Crawford(7), Francesca L. Garcia(7), Jan M. Orenstein(6), Michael A. Gerber(5), Masaru Terai(5), Annette Baker(4), Larry M. Baddour(4), Matthew E. Levison(4), Robert S. Baltimore(4), Lloyd Y. Tani(4), Robert O. Bonow(4), Thomas J. Pallasch(4), Patricia Ferrieri(4)